Lion Point Capital, LP — 13F holdings

Lion Point Capital, LP reported 35 holdings worth $20.9M in its 13F filing for Q2 2026, filed August 14, 2026.

Largest positions

1. CUE CUE BIOPHARMA INC — $1.67M (8.0%)
2. PRAX PRAXIS PRECISION MEDICINES I — $1.49M (7.1%)
3. MLTX MOONLAKE IMMUNOTHERAPEUTICS — $1.31M (6.3%)
4. FENC FENNEC PHARMACEUTICALS INC — $1.21M (5.8%)
5. RPRX ROYALTY PHARMA PLC — $1.20M (5.7%)
6. CMPS COMPASS PATHWAYS PLC — $1.13M (5.4%)
7. MIST MILESTONE PHARMACEUTICALS IN — $1.10M (5.3%)
8. BNTC Benitec Biopharma Inc — $830K (4.0%)
9. SNDX Syndax Pharmaceuticals Inc — $787K (3.8%)
10. BHVN BIOHAVEN LTD — $769K (3.7%)